Submission of Earnings Call Transcript
DEEPAKNTR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Deepak Nitrite reported Q4 FY26 consolidated revenue of INR 2,127 crore with EBITDA of INR 383 crore, delivering a strong 74% sequential improvement in EBITDA margin to 18%. The Phenolics segment drove much of the performance with EBIT margins of 20%, while Advanced Intermediates showed an 8% year-on-year revenue growth. Management highlighted that Q1 FY27 will be better than Q4 FY26, with FY27 expected to show a stronger margin profile on the back of 6-7 new products and fluorinated molecules scheduled for commercial production from Q3. The company cited China environmental regulations as a structural tailwind for its nitration products. Key project updates include MIBK/MIBC commissioning targeted for Q2 FY27 and the polycarbonate facility on track for June 2028. Total project capex of INR 11,000 crore is funded at a 60:40 debt-equity ratio.
The strong Q4 margin recovery and management's explicit guidance for continued improvement in Q1 and FY27 signals an earnings upturn. The upcoming new product launches and favorable geopolitical dynamics positioning Deepak as a reliable domestic supplier could support re-rating.